Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | MDM4 | O15151 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17196273 | 1.00 | KLK5 (0.46) | KLK5ACEMAPTTDP1KMT2A | |
| SCHEMBL29539925 | 1.00 | KLK5 (0.46) | KLK5ACEMAPTTDP1KMT2A | |
| SCHEMBL20646383 | 1.00 | KLK5 (0.46) | KLK5ACEMAPTTDP1KMT2A | |
| SCHEMBL30722033 | 0.91 | CTSS (0.47) | ACEMAPTTDP1CTSSCTSL | |
| SCHEMBL18495625 | 0.91 | CTSS (0.47) | ACEMAPTTDP1CTSSCTSL | |
| SCHEMBL30597646 | 0.91 | CTSS (0.47) | ACEMAPTTDP1CTSSCTSL | |
| SCHEMBL30597634 | 0.91 | CTSS (0.47) | ACEMAPTTDP1CTSSCTSL | |
| SCHEMBL27332954 | 0.91 | CTSS (0.47) | ACEMAPTTDP1CTSSCTSL | |
| SCHEMBL18495627 | 0.90 | ATM (0.48) | KMT2APOLB | |
| SCHEMBL31246036 | 0.89 | KMT2A (0.43) | KLK5ACEMAPTTDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025051124-A1 | AURISTATIN F ANALOGUE, ANTIBODY DRUG CONJUGATE AND USE THEREOF | 诺灵生物医药科技(北京)有限公司 | 2025-03-13 | — | — | WO | disclosed |